Halozyme Therapeutics Inc (HALO)

[Fred Kadiddlehopper]

Thanks for posting that. I rarely have access to analyst notes ao it's interesting to see what they are focused on.
Technically the pullback/consolidation phase is fulfilled, and I'm getting ready to replenish my trading shares, which were called away at $55, for the next leg up. Helen, despite her flaws, is reliable when she openly predicts pending deals, so with three in the works, added to a likely approval of SG Egartigimod, I think it's a good bet for at least a testing of the recent highs, if not a bona fide breakout. The latter would depend on how significant the larger of the new deals turns out to be.